High-Sensitivity Point of Care Cardiac Troponin I — Novel Whole Blood Testing at Last

Now on Demand

Fred Apple, PhD
Chair, IFCC Committee on Clinical Application of Cardiac Biomarkers (C-CB)
Member, AACC Academy Laboratory Medicine Practice Guidelines on Cardiac Markers
Member, Global Task Force of Universal Definition of Myocardial Infarction

|2021-08-24
Dr. Fred Apple

Fred Apple, PhD

Dr. Apple discusses the relevance and use of High-Sensitivity Troponin I in the ED setting at the Point of Care. Dr. Apple reviews hs-cTnI scientific literature and speaks to critical considerations pertaining to the set up and implementation of POC, considering the combined efforts of the laboratory and Emergency Department clinical staff.

  • Understand the clinical utilization of high-sensitivity troponin I as an aid in the diagnosis of Acute Myocardial Infarction
  • Appreciate the newest scientific data pertaining to novel POC high-sensitivity troponin I
  • Share key insights around the collaborative process among the laboratory and Emergency Department (ED) clinical staff

  • Those interested in the assessment and management of Acute Myocardial Infarction in the emergency setting
  • Those interested in reviewing data on the evolution of cardiac troponin performance and clinical utility
  • ED, laboratory, and/or administrators interested in potential improvements in emergency care and rapid disposition of patients with suspected AMI

Attendees are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC.

Webinar available on demand through August 24, 2023